Figma vs. UiPath: What Revenue Growth Trends Tell Investors About These Tech Companies

Figma reported record Q2 2026 revenue of $370.1 million, up 48% year over year, as its first full quarter of monetizing AI credits supported growth. Its revenue rose every quarter in the eight-quarter comparison, narrowing the gap with UiPath, whose Q2 2026 revenue was $410.3 million and whose results showed seasonal peaks and declines. The article highlights continued revenue momentum at Figma but notes that investors should watch whether growth persists and the gap keeps narrowing.

Analysis

The useful signal is mix, not the approaching revenue crossover. FIG’s acceleration may reflect paid AI usage layered onto its design product, but a first full quarter of credit monetization does not establish recurring seat expansion or durable consumption. Credit usage can lift near-term revenue while making growth less predictable; verify repeat usage, net retention, and whether AI revenue is incremental rather than substituting for existing plans. Its new design agent could also broaden adoption—or reduce the need for paid human seats over time. The data do not resolve that trade-off.

PATH’s quarterly volatility is partly consistent with enterprise purchasing cycles, so sequential declines alone are weak evidence of deterioration. The more important medium-term risk is whether automation budgets shift toward bundled AI features from large software platforms, compressing RPA pricing or lengthening sales cycles. Conversely, workflow orchestration and its Snowflake integration could strengthen its role in multi-system deployments; the commercial contribution is unquantified.

Near term, treat the revenue comparison as a weak trading signal: the companies’ reporting periods differ, and seasonality distorts sequential comparisons. Over 1–3 months, watch FIG’s next report for sustained AI-credit use and customer retention, and PATH’s bookings/ARR or guidance for evidence that the softer trajectory is more than timing. Over 6–18 months, competitive substitution and monetization quality matter more than which company reports the larger quarter. FIG’s lawsuit is a discrete headline risk, but the article provides no basis to size its financial exposure. No valuation or expectations data are supplied, so a FIG/PATH pair is a watchlist idea—not an entry signal.

Key Decisions for Investors

• Do not trade the apparent revenue crossover alone; compare year-over-year growth, ARR/remaining performance obligations, retention, and reported periods before drawing relative conclusions.
• Watch FIG’s next results for AI-credit repeat consumption, net retention, and whether growth persists beyond the initial monetization quarter. A deceleration in those measures would falsify the durable-acceleration thesis.
• Watch PATH bookings/ARR, guidance, and deal-cycle commentary over the next 1–3 months. Stabilization would weaken the structural-bear case; continued deterioration would support concern about competitive displacement, not just seasonality.
• Consider a valuation- and estimate-adjusted FIG-over-PATH pair only if FIG’s AI monetization proves repeatable and PATH’s forward indicators weaken; define entry and risk limits from current prices and consensus data, which are not provided here.
• Track the FIG class action for material developments, but avoid assigning an earnings impact absent disclosed exposure or a company update.